摘要
目的:探讨复方丹参滴丸治疗冠心病稳定型心绞痛的疗效。方法:治疗组应用复方丹参滴丸,对照组应用硝酸异山梨酯,对比观察两组用药后心绞痛缓解情况及心电图改善情况。结果:治疗组显效率69%,对照组为51%,两组差异有显著性(P<0.05);心电图ST-T段复常治疗组总有效率65.4%,对照组总有效率52.8%,两组比较差异有显著性(P<0.01)。结论:复方丹参滴丸是一种治疗稳定型心绞痛较为理想和安全的药物。
Objective ：To investigate the curative effect of compound danshendiwan in the treatment of stable angina pectoris in patients with coronary heart disease.Methods ：The treatment group was treated with compound danshendiwan,while the control group with isosorbide dinitrate.The remittent condition of angina pectoris and improvement condition of ECG in two groups were observed and compared respectively after treatment.Results：The effectual rate was 69% in the treatment group and 51% in the control group,with significant difference between two groups（P〈0.05）;The total effective rate of ECT ST-T segment normalization was 65.4% in the treatment group and 52.8% in the control group,with significant difference between them （P〈0.01）.Conclusion： Compound danshendiwan is a relatively ideal and safe drug for the treatment of stable angina pectoris in patients with coronary heart disease.
出处
《现代医药卫生》
2008年第19期2888-2889,共2页
Journal of Modern Medicine & Health
关键词
复方丹参滴丸
心绞痛
治疗
Compound danshendiwan
Angina pectoris
Treatment
